Marksans Pharma Ltd. Financials

NSE BSE

15:55 Jul 18

Marksans Pharma Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

255.75

-3.15 (-1.22%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

255.75

-3.15 (-1.22%)
15:55 Jul 18

Quality

61/100
High Financial Strength

Valuation

37/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	1376.18	1490.84	1852.14	2177.41	2622.84
Operating Expenses +	1036.57	1231.95	1512.82	1718.83	2094.2
Raw Material	731.33	703.92	927.75	1111.98	1327.5
Increase Decrease in Cost	-136.28	12.9	-6.39	-73.86	-183.76
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	197.32	220.3	239.37	293.64	350.3
Miscellaneous Expenses	867.34	621.33	981.65	1275.63	1749.12
Operating Profit	339.61	258.89	339.32	458.58	528.64
Other Income	6.69	41.85	59.31	50.42	70.38
Depreciation	36.15	44.78	51.85	74.27	83.39
Interest	7.99	8.45	9.13	11.2	11.66
Profit before tax and exceptio..	302.16	247.51	337.65	423.53	503.97
Exceptional Items	0	0	0	0	0
PBT	302.16	247.51	337.65	423.53	503.97
Provision for Taxation	63.63	60.7	72.33	108.63	121.35
Net Profit	238.54	186.81	265.32	314.9	382.62
NET Profit after MI	238.54	186.81	266.31	313.7	380.58
EPS	5.76	4.51	6.41	6.92	8.4
Operating Profit Margin (%)	24.68	17.37	18.32	21.06	20.16
Net Profit Margin (%)	17.33	12.53	14.38	14.41	14.51

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	43.90	43.90	43.90	43.90	43.90
FII	19.90	22.20	22.00	21.30	18.60
MF	3.60	3.40	3.20	3.00	2.80
Others	1.90	1.10	1.00	1.10	0.90

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: